Virtual: BIO International 2020

Track Sessions

Available on Demand for Registered Attendees

How to Get Paid for Digital Therapeutics 

Go to the Session

Current coverage trends in the U.S. and Europe, specific case studies of hurdles for DTx developers, and what is required to make a more persuasive case to payers.

Moderator:

• Chris Wright, Consulting

Panelists:

• Ed Pazella, Payer
• Jessica Shull, DTx Alliance
• Everett Crosland, appliedVR

Developing a New Diagnostic for a Rare Disease to Fuel Clinical Trials and Build a Market

Go to the Session

Case study of a collaboration between a pharma company and a national diagnostics lab that led to the commercialization of a quantitative diagnostic test for HDV.

Moderator:

• Alastair Smith, Clinical

Panelists: 

• Matt Bryant, Eiger Biopharmaceuticals
• Sierra Broder, Hepatitis B Foundation 
• Mridula Iyer, Quest Diagnostics

What Drug Pricing Policies Can the Executive Branch Enact without Congressional Authority?

Go to the Session

Deep dive into executive authority on healthcare policy, discuss what is and is not possible, and how things may change under a new administration. 

Moderator:

• Meg Alexander, Reputation & Risk Management

Panelists:

• Fritz Bittenbender, Genentech
• Remy Brim, PhD, BGR Government Affairs
• Alan Eisenberg, Alnylam
• Peter Pitts, Center for Medicine in the Public Interest